Exploring the etiology of Alzheimer disease using molecular genetics

C. L. Lendon, F. Ashall and A. M. Goate
Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA.

Alzheimer disease (AD), the most common cause of dementia in the elderly, exists in both familial and sporadic forms. Genetic studies have led to the identification of 3 genes, beta-amyloid precursor protein (APP), presenilin-1 (PS1), and presenilin-2 (PS2), which, when mutated, can cause familial forms of AD. Mutations in each of these genes result in elevated levels of A beta42/43, a proteolytic processing fragment of APP that is deposited in brains of AD patients. Transgenic mice carrying AD-causing mutations in APP develop spontaneous age-related beta-amyloid (A beta) deposition and memory impairment. Genetic linkage and association studies have also shown that the epsilon4 allele of the apolipoprotein E (APOE) gene increases risk for AD in a dose-dependent manner in both familial and sporadic forms of AD and may account for as much as 50% of the attributable risk. APOE genotyping may be useful both as an adjunct to diagnosis and in identifying patient groups for therapeutic intervention. While the biological basis for the association of APOE epsilon4 with AD is not known, age of onset and A beta deposition are positively correlated with epsilon4 allele dosage in some cases, suggesting that this risk may also be mediated directly or indirectly through A beta. Because 50% of AD cases have no APOE epsilon4 alleles and families showing mendelian inheritance of AD exist in whom there are no mutations in any of the APP, PS1, or PS2 genes, it is likely that there are additional AD risk factors, both genetic and environmental, still to be identified.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Amyloid-beta in Alzheimer Disease: The Null versus the Alternate Hypotheses
Lee et al.
J. Pharmacol. Exp. Ther. 2007;321:823-829.
ABSTRACT | FULL TEXT  

Depressive Symptoms Associated With Hereditary Alzheimer's Disease: A Case Description
Contreras et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2007;21:411-415.
ABSTRACT  

A Variant of the Sigma Receptor Type-1 Gene Is a Protective Factor for Alzheimer Disease
Uchida et al.
AJGP 2005;13:1062-1066.
ABSTRACT | FULL TEXT  

Linking Receptor-mediated Endocytosis and Cell Signaling: EVIDENCE FOR REGULATED INTRAMEMBRANE PROTEOLYSIS OF MEGALIN IN PROXIMAL TUBULE
Zou et al.
J. Biol. Chem. 2004;279:34302-34310.
ABSTRACT | FULL TEXT  

Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease
Levy et al.
Arch Neurol 2004;61:1033-1039.
ABSTRACT | FULL TEXT  

Androgens, ApoE, and Alzheimer's Disease
Raber
Sci Aging Knowl Environ 2004;2004:re2-re2.
ABSTRACT | FULL TEXT  

Screening for Presenilin Inhibitors Using the Free-Living Nematode, Caenorhabditis elegans
Ellerbrock et al.
J Biomol Screen 2004;9:147-152.
ABSTRACT  

Early onset autosomal dominant dementia with ataxia, extrapyramidal features, and epilepsy
Filla et al.
Neurology 2002;58:922-928.
ABSTRACT | FULL TEXT  

Twin Studies of Psychiatric Illness: An Update
Kendler
Arch Gen Psychiatry 2001;58:1005-1014.
ABSTRACT | FULL TEXT  

The {-}48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A{beta} load in brain
Lambert et al.
J. Med. Genet. 2001;38:353-355.
ABSTRACT | FULL TEXT  

Nature, nurture and mental disorder: old concepts in the new millennium
COOPER
Br. J. Psychiatry 2001;178 :s91-s101.
ABSTRACT | FULL TEXT  

Will Genetics Revolutionize Medicine?
Holtzman and Marteau
NEJM 2000;343:141-144.
FULL TEXT  

Failure To Detect Chlamydia pneumoniae in the Late-Onset Alzheimer's Brain
Ring and Lyons
J. Clin. Microbiol. 2000;38:2591-2594.
ABSTRACT | FULL TEXT  

Genetics of Human Aging: The Search for Genes Contributing to Human Longevity and Diseases of the Old
SLAGBOOM et al.
Ann. N. Y. Acad. Sci. 2000;908:50-63.
ABSTRACT | FULL TEXT  

Variant Alzheimer's disease with spastic paraparesis: Clinical characterization
Verkkoniemi et al.
Neurology 2000;54:1103-1109.
ABSTRACT | FULL TEXT  

Alzheimer Disease: Mouse Models Pave the Way for Therapeutic Opportunities
Emilien et al.
Arch Neurol 2000;57:176-181.
ABSTRACT | FULL TEXT  

Treatment of Alzheimer's Disease
Mayeux and Sano
NEJM 1999;341:1670-1679.
FULL TEXT  

Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis
Xu et al.
Proc. Natl. Acad. Sci. USA 1999;96:7547-7552.
ABSTRACT | FULL TEXT  

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
Hsia et al.
Proc. Natl. Acad. Sci. USA 1999;96:3228-3233.
ABSTRACT | FULL TEXT  

Evidence for a physical interaction between presenilin and Notch
Ray et al.
Proc. Natl. Acad. Sci. USA 1999;96:3263-3268.
ABSTRACT | FULL TEXT  

Genetic Susceptibility to Neurodevelopmental Disorders
Ryan
J Child Neurol 1999;14:187-195.
ABSTRACT  

Role of ERAB/L-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Abeta -induced Cytotoxicity
Du Yan et al.
J. Biol. Chem. 1999;274:2145-2156.
ABSTRACT | FULL TEXT  

Amyloid beta -Peptide Possesses a Transforming Growth Factor-beta Activity
Huang et al.
J. Biol. Chem. 1998;273:27640-27644.
ABSTRACT | FULL TEXT  

Panic and Phobic Anxiety: Defining Phenotypes for Genetic Studies
Smoller and Tsuang
Am. J. Psychiatry 1998;155:1152-1162.
ABSTRACT | FULL TEXT  

Premature Alzheimer Disease Was Not Due to Trauma: Molecular Biology Revises Diagnosis 15 Years After Patient's Autopsy
Abuelo et al.
Arch Neurol 1998;55:1155-1155.
FULL TEXT  

Modulation of Secreted beta -Amyloid Precursor Protein and Amyloid beta -Peptide in Brain by Cholesterol
Howland et al.
J. Biol. Chem. 1998;273:16576-16582.
ABSTRACT | FULL TEXT  

Amyloid Protein Precursor Stimulates Excitatory Amino Acid Transport. IMPLICATIONS FOR ROLES IN NEUROPROTECTION AND PATHOGENESIS
Masliah et al.
J. Biol. Chem. 1998;273:12548-12554.
ABSTRACT | FULL TEXT  

Epidemiology of Dementia and Alzheimer's Disease
Hendrie
AJGP 1998;6:3S-18.
ABSTRACT | FULL TEXT  

Consensus Statement on Alzheimer Disease
Ania et al.
JAMA 1998;279:655-656.
FULL TEXT  

Interaction of Presenilins with the Filamin Family of Actin-Binding Proteins
Zhang et al.
J. Neurosci. 1998;18:914-922.
ABSTRACT | FULL TEXT  

Increased Susceptibility to Ischemic Brain Damage in Transgenic Mice Overexpressing the Amyloid Precursor Protein
Zhang et al.
J. Neurosci. 1997;17:7655-7661.
ABSTRACT | FULL TEXT  

A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred
Vidal et al.
Proc. Natl. Acad. Sci. USA 2000;97:4920-4925.
ABSTRACT | FULL TEXT  

Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques
Koistinaho et al.
Proc. Natl. Acad. Sci. USA 2001;98:14675-14680.
ABSTRACT | FULL TEXT